Analyst
Wolfe Research
Equibles does not estimate personal net worth.
Brandon is recorded as Analyst at Wolfe Research. Brandon has spoken on 3 earnings calls and 1 other investor event across 4 companies, most recently for INSMED Inc on August 6, 2026. Those appearances were for INSMED Inc (INSM), Madrigal Pharmaceuticals, Inc. (MDGL), Werner Enterprises Inc (WERN) and Sarepta Therapeutics, Inc. (SRPT). The companies whose calls Brandon spoke on are classified in the Healthcare and Industrials sectors.
“So, curious to know, what was the reason for the lower GTN? Was it Medicare patients fewer than previously anticipated, rebates less stringent than previously anticipated?”
“We're curious to know if you can rank order the different NASH combos that you have. Which one are you most excited about clinically? Thank you.”
“Derek, I appreciate you coming to the conference. Sounds like maybe you're a little bit more enthusiastic on demand here, maybe not just all supply that we're seeing in the market.”
“Regarding your floor assumptions on elevated fails, to what degree are you factoring competitive pressures from emerging therapies?”
Wolfe Research
Analyst
Transcript header (unverified)
INSM
Biotechnology · Healthcare
